Mitochondrial disease
Gene: ACADSB
Established gene-disease association
2-Methylbutyryl-CoA dehydrogenase (MBD) deficiency is an autosomal recessive metabolic disorder of impaired isoleucine degradation, a mitochondrial disorder of fatty acid β-oxidation. A defect in the substrate-generating upstream reactions of OXPHOS. >3 cases reported. Cases are usually asymptomatic, but can have neurological symptoms.Created: 22 Mar 2022, 12:57 a.m. | Last Modified: 22 Mar 2022, 12:57 a.m.
Panel Version: 0.11708
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
2-methylbutyrylglycinuria MIM#610006
Publications
2-Methylbutyryl-CoA dehydrogenase (MBD) deficiency is an autosomal recessive metabolic disorder of impaired isoleucine degradation, a mitochondrial disorder of fatty acid β-oxidation. A defect in the substrate-generating upstream reactions of OXPHOS. >3 cases reported. Cases are usually asymptomatic, but can have neurological symptoms.
Sources: NHS GMS, LiteratureCreated: 21 Mar 2020, 6:32 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
2-methylbutyrylglycinuria MIM#610006
Publications
Gene: acadsb has been classified as Green List (High Evidence).
Gene: acadsb has been classified as Green List (High Evidence).
gene: ACADSB was added gene: ACADSB was added to Mitochondrial disease. Sources: NHS GMS,Literature Mode of inheritance for gene: ACADSB was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ACADSB were set to 25778941; 17945527 Phenotypes for gene: ACADSB were set to 2-methylbutyrylglycinuria MIM#610006 Review for gene: ACADSB was set to GREEN